Abstract
The focus of this chapter will be different from the others in this book as it takes a more holistic view of the organism. Such a view examines hyperalgesia from an adaptive perspective and makes the argument that exaggeration of pain is a natural and normal consequence of immune activation. During illness, infection, and injury, activated immune cells release substances that signal the brain, triggering a constellation of coordinated responses designed to enhance survival (for review, see Ref [1, 2]). Hyperalgesia will be argued to be simply one component of this brain-mediated illness response. There has been increasing recognition that the immune system is involved in the regulation of many diverse phenomena to which it has not previously thought to be relevant [2], and here we will argue that pain is such a phenomenon.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Watkins LR, Maier SF, Goehler LE (1995) Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci 57: 1011–26
Maier SF, Watkins LR (1997) Cytokines for psychologists: implications of bi-directional immune-to-brain communication for understanding behavior, mood, and cognition. Psych Rev 105: 83–107
Kuby J (1992) Immunology. W. H. Freeman & Co., New York
Nathan CF (1987) Secretory products of macrophages. J Clin Invest 79: 319–326
Decker K (1990) Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 192: 245–261
Hart BL (1988) Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 12: 123–137
Watkins LR, Maier SF, Goehler LE (1995) Immune activation: the role of pro-inflam-matory cytokines in inflammation, illness responses and pathological pain states. Pain 63: 289–302
Kluger MJ (1991) Fever: role of pyrogens and cryogens. Physiol Rev 71: 93–127
Moltz H (1993) Fever: causes and consequences. Neurosci Biobehav Rev 17: 237–269
Maier SF, Watkins LR, Fleshner M (1994) Psychoneuroimmunology: the interface between behavior, brain, and immunity. Amer Psych 49: 1001–1018
Kent S, Bluthe R-M, Kelley KW, Dantzer R (1992) Sickness behavior as a new target for drug development. Trends in Pharmacol Sci 13: 24–28
Rothwell NJ, Luheshi G (1994) Pharmacology of interleukin-1 actions in the brain. Adv Pharmacol 25: 1–20
Walters ET (1994) Injury-related behavior and neuronal plasticity: an evolutionary perspetive on sensitization, hyperalgesia, and analgesia. Int Rev Neurobiol 36: 325–427
Dunn AJ (1993) Role of cytokines in infection-induced stress. Ann NY Acad Sci 697: 189–202
Dunn AJ (1988) Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. Life Sci 43: 429–435
Wan W, Wetmore L, Sorensen CM, Greenberg AH, Nance DM (1994) Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain. Brain Res Bull 34: 7–14
Ericsson A, Kovacs KJ, Sawchenko PE (1994) A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 14: 897–913
Saphier D (1989) Neurophysiological and endocrine consequences of immune activity. Psychoneuroendo 14: 63–87
Ban E, Haour F, Lenstra R (1992) Brain interleukinl gene expression induced by peripheral lipopolysaccharide administration. Cytokine 4: 48–54
Gatti S, Bartfai T (1993) Induction of tumor necrosis factor-a mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin6. Brain Res 624: 291–294
Laye S, Bluthe R-M, Kent S, Combe C, Medina C, Parnet P, Kelley K, Dantzer R (1995) Subdiaphragmatic vagotomy blocks the induction of interleukin-1ß mRNA in the brain of mice in response to peripherally administered lipopolysaccharide. Am J Physiol 268: R1327–R1331
Miller NE (1961) Some psychophysiological studies of motivation and of the behavioral effects of sickness. Bull Brit Psych Soc 17: 1–20
Aubert A, Kelley KW, Dantzer R (1997) Differential effect of lipopolysaccharide on food hoarding behavior and food consumption in rats. Brain, Behavior & Immunity 11: 229–238
Wall PD (1979) On the relation of injury to pain. The John J. Bonica lecture. Pain 6: 253–264
Maier SF, Wiertelak EP, Martin D, Watkins LR (1993) Interleukin-1 mediates behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res 623: 321–324
Wiertelak EP, Smith KP, Furness L, Mooney-Heiberger K, Mayr T, Maier SF, Watkins LR (1994) Acute and conditioned hyperalgesic responses to illness. Pain 56: 227–234
Mason P (1993) Lipopolysaccharide induces fever and decreases tail flick latency in awake rats. Neurosci Lett 154: 134–136
Watkins LR, Wiertelak EP, Goehler LE, Smith KP, Martin D, Maier SF (1994) Characterization of cytokine-induced hyperalgesia. Brain Res 654: 15–26
Watkins LR, Goehler LE, Relton J, Brewer MT, Maier SF (1995) Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res 692: 244–250
Watkins LR, Wiertelak EP, Goehler LE, Mooney-Heiberger K, Martinez J, Furness L, Smith KP, Maier SF (1994) Neurocircuitry of illness-induced hyperalgesia. Brain Res 639: 283–299
Goehler LE, Gaykema RPA, Tilders FJH, Maier SF, Watkins LR (1996) Endotoxin induces Fos immunoreactivity in rat vagal sensory ganglion cells. In: International Society for Neuroimmunomodulation. Washington, DC
Gaykema RPA, Goehler LE, McGorry MM, Milligan ED, Fleshner M, Tilders FJH, Maier SF, Watkins LR (1997) Subdiaphragmatic vagotomy inhibits fos expression in brain and pituitary after intraperitoneal but not intravenous administration of endotoxin. Proc Soc Neurosci 23: 1514
Hammack SE, Nguyen KT, Hinde JL, Gaykema RPA, Goehler LE, Maier SF, Watkins LR (1998) Does IL-1beta activate the vagus nerve? LPS induces IL-Ibeta in the vagus nerve and intraperitoneal IL1beta injections increase firing rate in vagal afferents. In: Psychoneuroimmunology Research Society meeting. Bristol, England
Niijima A (1996) The afferent discharges from sensors for interleukin 1 beta in the hepatoportal system in the anesthetized rat. J Auton Nery Syst 61: 287–291
Goehler LE, Relton JK, Dripps D, Kiechle R, Tartaglia N, Maier SF, Watkins LR (1997) Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist (IL-1ra) in the rat: a possible mechanism for immune-to-brain communication. Brain Res Bull 43: 357–364
Morgan M, Pack RJ, Howe A (1976) Structure of cells and nerve endings in abdominal vagal paraganglia of the rat. Cell Tiss Res 169: 467–484
Berthoud H-R, Powley TL (1993) Characterization of vagal innervation to the rat celiac, suprarenal and mesenteric ganglia. J Auto Nery Sys 42: 153–170
Ritter S, Ritter RC, Barnes CD (eds) (1992) Neuroanatomy and physiology of abdominal vagal afferents. CRC Press, Ann Arbor
Wiertelak EP, Roemer B, Maier SF, Watkins LR (1997) Comparison of the effects of nucleus tractus solitarius and ventral medulla lesions on illness-induced and subcutaneous formalin-induced hyperalgesias. Brain Res 748: 143–150
Wiertelak EP, Furness LE, Watkins LR, Maier SF (1994) Illness-induced hyperalgesia is mediated by a spinal NMDA-nitric oxide cascade. Brain Res 664: 9–16
Watkins LR, Wiertelak EP, Furness LE, Maier SF (1994) Illness-induced hyperalgesia is mediated by spinal neuropeptides and excitatory amino acids. Brain Res 664: 17–24
Wiertelak EP, Furness LE, Horan R, Martinez J, Maier SF, Watkins LR (1994) Subcutaneous formalin produces centrifugal hyperalgesia at a non-injected site via the NMDAnitric oxide cascade. Brain Res 649: 19–26
Watkins LR, Deak T, Silbert L, Martinez J, Goehler L, Relton J, Martin D, Maier SF (1995) Evidence for involvement of spinal cord glia in diverse models of hyperalgesia. Proc Soc Neurosci 21: 897
Watkins LR, Martin D, Ulrich P, Tracey KJ, Maier SF (1997) Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 71: 225–235.
Meller ST, Dyskstra C, Grzybycki D, Murphy S, Gebhart GF (1994) The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacol 33: 1471–1478
Nguyen KT, Deak T, Owens SM, Fleshner M, Watkins LR, Maier SF (1997) Effects of LPS and acute stress on rat brain interleukin-1beta. Proc Soc Neurosci 23: 715
Buttini M, Boddeke H (1995) Peripheral lipopolysaccharide stimulation induces interleukin-1b messenger RNA in rat brain microglial cells. Neurosci 65: 523–530
VanDam AM, Brouns M, Louisse S, Berkenbosch F (1992) Appearance of interluekin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? Brain Res 588: 291–298
Martin FC, Charles AC, Sanderson MJ, Merrill JE (1992) Substance P stimulates IL-1 production by astrocytes via intracellular calcium. Brain Res 599: 13–18
Martin FC, Anton PA, Gornbein JA, Shanahan F, Merrill JE (1993) Production of interleukin-1 by microglia in response to substance P: role for a non-classical NK-1 receptor. J Neuroimmunol 42: 53–60
Luber-Narod J, Kage R, Leeman SE (1994) Substance P enhances the secretion of tumor necrosis factor-alpha from neuroglial cells stimulated with lipopolysaccharide. J Immunol 152: 819–824
Ericsson A, Liu C, Hart RP, Sawchenko PE (1995) Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J Comp Neurol 361: 681–698
Takao T, Hashimoto K, DeSouza EB (1995) Interleukin-1 receptors in the brainendocrine-immune axis. Ann NY Acad Sci 771: 372–385
Relton JK, Rothwell NJ (1992) Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 29: 243–246
Hewett SJ, Corbett JA, McDaniel ML, Choi DW (1993) Interferon-gamma and interleukin-]beta induce nitric oxide formation from primary mouse astrocytes. Neurosci Lett 164: 229–232
Marriott D, Wilkin GP, Coote PR, Wood JN (1991) Eicosanoid synthesis by spinal cord astrocytes is evoked by substance P; possible implications for nociception and pain. Adv Prostaglandin Thromboxane Leukot Res 21B: 739–741
Malmberg AB, Rafferty MF, Yaksh TL (1994) Antinociceptive effect of spinally delivered prostaglandin E receptor antagonists in the formalin test on the rat. Neurosci Lett 173: 193–196
Yamamoto T, Shimoyama N, Mizuguchi T (1993) Nitric oxide synthase inhibitor blocks spinal sensitization induced by formalin injection into the rat paw. Anesth Analg 77: 886–890
Oka T, Aou S, Hori T (1994) Intracerebroventircula injection of interleukin-1 beta enhances nociceptive neuronal responses of the trigeminal nucleus caudalis in rats. Brain Res 656: 236–244
Gadient RA, Cron KC, Otten U (1990) Interleukin-113 and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci Lett 117: 335–340
Carman-Krzan M, Vige X, Wise BC (1991) Regulation by interleukin-1 of nerve growth factor secretion and nerve growth factor mRNA expression in rat primary astroglial cultures. J Neurochem 56: 636–643
Pechan PA, Chowdhury K, Gerdes W, Seifert W (1993) Glutamate induces the growth factors NGF, bFGF, the receptor FGF-R1 and c-fos mRNA expression in rat astrocyte culture. Neurosci Lett 153: 111–114
Hattori A, Tanaka E, Murase K, Ishida N, Chatani Y, Tsujimoto M, Hayashi K, Kohno M (1993) Tumor necrosis factor stimulates the synthesis and secretion of biologically actie nerve growth factor in non-neuronal cells. J Biol Chem 268: 2577–2582
Friedman WJ, Larkfors L, Ayer-LeLievre C, Ebendal T, Olson L, Persson H (1990) Regulation of beta-nerve growth factor expression by inflammatory mediators in hippocampal cultures. J Neurosci Res 27: 374–382
Averill S, McMahon SB, Clary DO, Reichardt LF, Preistley JV (1994) Immunocytochemical localisation of trkA receptors in chemically identified subgrouops of adult sensory neurones. Eur J Neurosci 1484–1494
Verge VM, Richardson PM, Benoit R, Riopelle RJ (1989) Histochemical characterization of sensory neurons with high-affinity receptors for nerve growth factor. J Neurocytol 18: 583–591
Yip HK, Johnson EM (1987) Nerve growth factor receptors in rat spinal cord: an autoradiographic and immunohistochemical study. Neurosci 22: 267–279
Verge VM, Richardson PM, Wiesenfeld-Hallin Z, Hokfelt T (1995) Differential influence of nerve growth factor on neuropeptide expression in vivo: a novel role in peptide suppression in adult sensory neurons. J Neurosci 15: 2081–2096
Coderre TJ, Melzack R (1992) The role of NMDA receptor-operated calcium channels in persistent nociception after formalin-induced tissue injury. J Neurosci 12: 3671–3675
Coderre TJ, Melzack R (1992) The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12: 3665–3670
Coderre TJ, Katz J, Vaccarino AL, Melzack R (1993) Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52: 259–285
Skilling SR, Smullin DH, Beitz AJ, Larson AA (1988) Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation. J Neurochem 51: 127–132
Smullin DH, Skilling SR, Larson AA (1990) Interactions between substance P, calcitonin gene-related peptide, taurine, and excitatory amino acids in the spinal cord. Pain 42: 93–101
Garrison CJ, Dougherty PM, Kajander KC, Carlton SM (1991) Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 565: 1–7
Agullo L, Baltrons MA, Garcia A (1995) Calcium-dependent nitric oxide formation in glial cells. Brain Res 686: 160–168
Simmons ML, Murphy S (1992) Induction of nitric oxide synthase in glial cells. J Neurochem 59: 897–905
McKenna MC, Sonnewald U, Huang X, Stevenson J, Zielke HR (1996) Exogenous glutamate concentration regulates the metabolic fate of glutamate in astrocytes. J Neurochem 66: 386–393
Stella N, Tence M, Glowinski J, Premont J (1994) Glutamate-evoked release of arachidonic acid from mouse brain astrocytes. J Neurosci 14: 568–75
Hartung H-P, Heininger K, Schafer B, Toyka KV (1988) Substance P and astrocytes: stimulation of the cyclooxygenase pathway of arachidonic acid metabolism. FASEB J 2: 48–51
Marriott DR, Wilkin G, Wood JN (1991) Substance P-induced release of prostaglandins from astrocytes: regional specialisation and correlation with phosphoinositol metabolism. J Neurochem 56: 259–265
Dutton G (1993) Astrocyte amino acids: evid)ence for release and possible interactions with neurons. In: Murphy S (ed): Astrocytes: Pharmacology and function. Academic Press, San Diego, 173–192
Muller CM (1992) A role for glial cells in activity-dependent central nervous plasticity? Review and hypothesis. Internat Rev Neurobiol 34: 215–281
Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG (1994) Glutamate-mediated astrocyte-neuron signalling. Nature 369: 744–747
Paini D, Frei K, Pfister HW, Fontana A (1993) Glutamate uptake by astrocytes is inhibited by reactive oxygen intermediates but not by other macrophage-derived molecules including cytokines, leukotrienes or platelet-activating factor. J Neuroimmunol 48: 153–156
Barbour B, Szatkowshi M, Ingledew N, Attwell D (1989) Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells. Nature 342: 918–920
McBean GJ, Doorty KB, Tipton KF, Kollegger H (1995) Alteration in the glial cell metabolism of glutamate by kainate and N-methyl-D-aspartate. Toxicon 33: 569–576
Merrill JE, Koyanagi Y, Zack J, Thomas L, Martin F, Chen IS (1992) Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol 66: 2217–2225
Koka P, He K, Zack JA, Kitchen S, Peacock W, Fried I, Tran T, Yashar SS, Merrill JE (1995) Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J Exp Med 182: 941–951
Lipton SA, Yeh M, Dreyer EB (1994) Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide. Adv Neuroimmunol 4: 181–8
Dreyer EB, Lipton SA (1995) The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur J Neurosci 7: 2502–2507
Clouse KA, Cosentino LM, Weih KA, Pyle SW, Ribbins PB, Hochstein HD, Natarajan V, Farrar WL (1991) The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol 147: 2892–2901
Milligan ED, Hinde JL, Maier SF, Watkins LR (1997) The HIV-1 coat protein, gp120, produces thermal hyperalgesia in rats. Proc Soc Neurosci 23: 1805
Sundar SK, Cierpial MA, Kamaraju LS, Long S, Hsieh S, Lorenz C, Aaron M, Ritchie JC, Weiss JM (1991) Human immunodeficiency virus glycoprotein (gp120) infused intorat brain induces interleukin 1 to elevate pituitary-adrenal activity and decrease peripheral cellular immune responses. Proc Natl Acad Sci 88: 11246–11250
Davis, AJ, Perkins MN (1994) The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat. Brit J Pharmacol 113: 63–68
Davis AJ, Perkins MN (1996) Substance P and capsaicin-induced mechanical hyperalgesia in the rat knee joint: the involvement of bradykinin B1 and B2 receptors. Brit J Pharmacol 118: 2206–2212
Watkins LR, Maier SF (1997) The case of the missing brain: arguments for a role of brain-to-spinal cord pathways in pain facilitation. Behav Brain Sci 20: 469
Cesser RM, Koo SC (1997) Latent herpes simplex virus type 1 gene expression in ganglia innervating the human gastrointestinal tract. J Virol 71: 4103–4106
Gesser RM, Valyi-Nagy T, Altschuler SM, Fraser NW (1994) Oral-oesophageal inoculation of mice with herpes simplex virus type I causes latent infection of the vagal sensory ganglia (nodose ganglia). J Gen Virol 75: 2379–2386
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Basel AG
About this chapter
Cite this chapter
Watkins, L.R., Maier, S.F. (1999). Illness-induced hyperalgesia: Mediators, mechanisms and implications. In: Watkins, L.R., Maier, S.F. (eds) Cytokines and Pain. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8749-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8749-6_3
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9756-3
Online ISBN: 978-3-0348-8749-6
eBook Packages: Springer Book Archive